McKinsey To Advise On Global Integration Between Sun, Ranbaxy
This article was originally published in PharmAsia News
Executive Summary
Global consulting firm McKinsey is tasked with creating an integration roadmap between Sun Pharma and Ranbaxy, the two Indian generic giants that leaped to the fifth rank in the global generics pecking order with a deal announced in April.